Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;9(8):817-823.
doi: 10.1177/2048872620974605. Epub 2020 Nov 21.

Cardiac complications in patients hospitalised with COVID-19

Affiliations

Cardiac complications in patients hospitalised with COVID-19

Marijke Linschoten et al. Eur Heart J Acute Cardiovasc Care. 2020 Dec.

Abstract

Aims: To determine the frequency and pattern of cardiac complications in patients hospitalised with coronavirus disease (COVID-19).

Methods and results: CAPACITY-COVID is an international patient registry established to determine the role of cardiovascular disease in the COVID-19 pandemic. In this registry, data generated during routine clinical practice are collected in a standardised manner for patients with a (highly suspected) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection requiring hospitalisation. For the current analysis, consecutive patients with laboratory confirmed COVID-19 registered between 28 March and 3 July 2020 were included. Patients were followed for the occurrence of cardiac complications and pulmonary embolism from admission to discharge. In total, 3011 patients were included, of which 1890 (62.8%) were men. The median age was 67 years (interquartile range 56-76); 937 (31.0%) patients had a history of cardiac disease, with pre-existent coronary artery disease being most common (n=463, 15.4%). During hospitalisation, 595 (19.8%) patients died, including 16 patients (2.7%) with cardiac causes. Cardiac complications were diagnosed in 349 (11.6%) patients, with atrial fibrillation (n=142, 4.7%) being most common. The incidence of other cardiac complications was 1.8% for heart failure (n=55), 0.5% for acute coronary syndrome (n=15), 0.5% for ventricular arrhythmia (n=14), 0.1% for bacterial endocarditis (n=4) and myocarditis (n=3), respectively, and 0.03% for pericarditis (n=1). Pulmonary embolism was diagnosed in 198 (6.6%) patients.

Conclusion: This large study among 3011 hospitalised patients with COVID-19 shows that the incidence of cardiac complications during hospital admission is low, despite a frequent history of cardiovascular disease. Long-term cardiac outcomes and the role of pre-existing cardiovascular disease in COVID-19 outcome warrants further investigation.

Keywords: COVID-19/coronavirus; cardiac complications; cohorts; patient registry; pulmonary embolism.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The author(s) declare that there is no conflict of interest.

References

    1. Johns Hopkins Coronavirus Research Center. https://coronavirus.jhu.edu/map.html (accessed 15 November 2020).
    1. Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506. DOI: 10.1016/S0140-6736(20)30183-5 - DOI - PMC - PubMed
    1. Wang D, Hu B, Hu C, et al.. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061–1069. DOI: 10.1001/jama.2020.1585 - DOI - PMC - PubMed
    1. Shi S, Qin M, Shen B, et al.. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020; e200950. DOI: 10.1001/jamacardio.2020.0950 - DOI - PMC - PubMed
    1. Guo T, Fan Y, Chen M, et al.. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; e201017. DOI: 10.1001/jamacardio.2020.1017 - DOI - PMC - PubMed

MeSH terms